Melanoma in Peru: 1000 patients and 10 years of experience
The sociodemographic features of Peruvian patients with melanoma are different from other populations. There were higher stages without access to immunotherapy, therefore EFS and OS rates were worse than international reports, while prognostic factors were similar. Urgent healthcare policy changes are needed as is access to immunotherapy.
Authors
- Jiddu Guart
- J Concha
- J.C. Haro Varas (ORCID: https://orcid.org/0000-0003-0678-585X)
- Jorge Dunstan Yataco
- Camila Franco-Mesa (ORCID: https://orcid.org/0000-0001-6125-6825)
- Gonzalo Ziegler‐Rodriguez (ORCID: https://orcid.org/0000-0002-8486-8477)
- Anshumi Desai (ORCID: https://orcid.org/0000-0002-6134-1349)
- Gabriel De la Cruz Ku (ORCID: https://orcid.org/0000-0003-4203-3890)
- Sandro Casavilca‐Zambrano (ORCID: https://orcid.org/0000-0001-8406-739X)
- Luis Piedra-Delgado (ORCID: https://orcid.org/0009-0005-2844-2374)
- Jose Galarreta Zegarra
- Sheyla Diaz-Mora
- Sheila Vilchez Santillan
Institutions
- University of Miami (US)
- University of Massachusetts Chan Medical School (US)
- Universidad Científica del Sur (PE)
- Skin Cancer Foundation (US)
- Instituto Nacional de Enfermedades Neoplásicas (PE)
- The University of Texas Medical Branch at Galveston (US)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-10-08
- DOI
- https://doi.org/10.1371/journal.pone.0323636
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00